InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tenaya Therapeutics, Inc.

TNYA Clue Score23
United States Fiscal year ends December CIK 0001858848 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

96
Insider
Date
Role
Action
Shares
Price
Amount
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
2,279
$0.71
$1.62K
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
1,871
$0.71
$1.33K
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
1,637
$0.71
$1.16K
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
1,637
$0.71
$1.16K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
7,406
$0.71
$5.26K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
5,020
$0.71
$3.56K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
3,969
$0.71
$2.82K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
5,837
$0.71
$4.14K
Tomohiro Higa
18 May 2026
SVP, Finance
Sell
1,485
$0.79
$1.18K
Whittemore Tingley
18 May 2026
Chief Medical Officer
Sell
3,121
$0.79
$2.48K
Faraz Ali
18 May 2026
Chief Executive Officer
Sell
3,390
$0.79
$2.69K
Column Group III Gp, LP
25 Feb 2026
10% owner
Sell indirect
1,862,545
$0.56
$1.05M
Column Group III Gp, LP
25 Feb 2026
10% owner
Sell indirect
1,649,281
$0.56
$927.56K
Column Group III Gp, LP
24 Feb 2026
10% owner
Sell indirect
349,212
$0.62
$214.87K
Column Group III Gp, LP
24 Feb 2026
10% owner
Sell indirect
309,228
$0.62
$190.27K
Column Group III Gp, LP
23 Feb 2026
10% owner
Sell indirect
162,291
$0.60
$96.92K
Column Group III Gp, LP
23 Feb 2026
10% owner
Sell indirect
143,709
$0.60
$85.82K
Column Group III Gp, LP
20 Feb 2026
10% owner
Sell indirect
277,769
$0.61
$170.80K
Column Group III Gp, LP
20 Feb 2026
10% owner
Sell indirect
245,965
$0.61
$151.24K
Whittemore Tingley
17 Feb 2026
Chief Medical Officer
Sell
1,876
$0.64
$1.21K
Whittemore Tingley
17 Feb 2026
Chief Medical Officer
Sell
1,642
$0.64
$1.06K
Whittemore Tingley
17 Feb 2026
Chief Medical Officer
Sell
1,642
$0.64
$1.06K
Faraz Ali
17 Feb 2026
Chief Executive Officer
Sell
5,032
$0.64
$3.24K
Faraz Ali
17 Feb 2026
Chief Executive Officer
Sell
3,979
$0.64
$2.56K
Faraz Ali
17 Feb 2026
Chief Executive Officer
Sell
5,851
$0.64
$3.76K
Tomohiro Higa
17 Feb 2026
SVP, Finance
Sell
2,022
$0.64
$1.30K
Tomohiro Higa
17 Feb 2026
SVP, Finance
Sell
836
$0.64
$537.88
Tomohiro Higa
17 Feb 2026
SVP, Finance
Sell
611
$0.64
$393.12
Column Group III Gp, LP
11 Feb 2026
10% owner
Sell indirect
2,151,458
$0.68
$1.46M
Column Group III Gp, LP
11 Feb 2026
10% owner
Sell indirect
1,905,115
$0.68
$1.30M
Column Group III Gp, LP
10 Feb 2026
10% owner
Sell indirect
182,295
$0.82
$148.77K
Column Group III Gp, LP
10 Feb 2026
10% owner
Sell indirect
161,422
$0.82
$131.74K
Faraz Ali
17 Nov 2025
Chief Executive Officer
Sell
3,126
$1.33
$4.16K
Whittemore Tingley
17 Nov 2025
Chief Medical Officer
Sell
2,877
$1.33
$3.83K
Tomohiro Higa
17 Nov 2025
SVP, Finance
Sell
1,367
$1.33
$1.82K
Faraz Ali
18 Aug 2025
Chief Executive Officer
Sell
4,920
$1.25
$6.16K
Faraz Ali
18 Aug 2025
Chief Executive Officer
Sell
3,893
$1.25
$4.88K
Faraz Ali
18 Aug 2025
Chief Executive Officer
Sell
5,720
$1.25
$7.17K
Whittemore Tingley
18 Aug 2025
Chief Medical Officer
Sell
1,837
$1.25
$2.30K
Whittemore Tingley
18 Aug 2025
Chief Medical Officer
Sell
1,608
$1.25
$2.01K
Whittemore Tingley
18 Aug 2025
Chief Medical Officer
Sell
1,608
$1.25
$2.01K
Tomohiro Higa
18 Aug 2025
SVP, Finance
Sell
1,722
$1.25
$2.16K
Tomohiro Higa
18 Aug 2025
SVP, Finance
Sell
717
$1.25
$898.40
Tomohiro Higa
18 Aug 2025
SVP, Finance
Sell
523
$1.25
$655.32
Faraz Ali
16 May 2025
Chief Executive Officer
Sell
3,189
$0.44
$1.41K
Whittemore Tingley
16 May 2025
Chief Medical Officer
Sell
2,937
$0.44
$1.30K
Tomohiro Higa
16 May 2025
SVP, Finance
Sell
1,390
$0.44
$615.35
Faraz Ali
10 Mar 2025
Chief Executive Officer
Sell
3,947
$0.54
$2.13K
Faraz Ali
10 Mar 2025
Chief Executive Officer
Sell
5,794
$0.54
$3.12K
Whittemore Tingley
10 Mar 2025
Chief Medical Officer
Sell
1,598
$0.54
$860.36
Whittemore Tingley
10 Mar 2025
Chief Medical Officer
Sell
4,073
$0.54
$2.19K
Whittemore Tingley
10 Mar 2025
Chief Medical Officer
Sell
1,727
$0.54
$929.82
Tomohiro Higa
10 Mar 2025
SVP, Finance
Sell
845
$0.54
$454.95
Tomohiro Higa
10 Mar 2025
SVP, Finance
Sell
620
$0.54
$333.81
Tomohiro Higa
10 Mar 2025
SVP, Finance
Sell
1,017
$0.54
$547.55
David Goeddel V
5 Mar 2025
Director
Buy indirect
35,714,284
$0.70
$25.00M
Column Group III Gp, LP
5 Mar 2025
10% owner
Buy indirect
35,714,284
$0.70
$25.00M
Chihiro Saito
18 Nov 2024
SVP, Accounting and Fin. Ops.
Sell
2,258
$2.12
$4.79K
Faraz Ali
16 Aug 2024
Chief Executive Officer
Sell
3,946
$2.89
$11.42K
Faraz Ali
16 Aug 2024
Chief Executive Officer
Sell
5,802
$2.89
$16.79K
Whittemore Tingley
16 Aug 2024
Chief Medical Officer
Sell
1,625
$2.89
$4.70K
Whittemore Tingley
16 Aug 2024
Chief Medical Officer
Sell
5,803
$2.89
$16.80K
Chihiro Saito
16 Aug 2024
SVP, Accounting and Fin. Ops.
Sell
807
$2.89
$2.34K
Chihiro Saito
16 Aug 2024
SVP, Accounting and Fin. Ops.
Sell
654
$2.89
$1.89K
Chihiro Saito
16 Aug 2024
SVP, Accounting and Fin. Ops.
Sell
902
$2.89
$2.61K
Timothy Hoey
5 Mar 2024
Chief Scientific Officer
Sold on a plan
3,300
$7.00
$23.10K
Timothy Hoey
20 Feb 2024
Chief Scientific Officer
Sold on a plan
200
$6.17
$1.23K
Timothy Hoey
20 Feb 2024
Chief Scientific Officer
Sold on a plan
6,369
$5.31
$33.81K
Faraz Ali
16 Feb 2024
Chief Executive Officer
Sell
6,358
$5.86
$37.26K
Leone D Patterson
16 Feb 2024
Chief Fin. and Bus. Officer
Sell
5,201
$5.86
$30.48K
Whittemore Tingley
16 Feb 2024
Chief Medical Officer
Sell
6,500
$5.86
$38.09K
Timothy Hoey
16 Feb 2024
Chief Scientific Officer
Sell
4,681
$5.86
$27.43K
David Goeddel V
12 Feb 2024
Director
Buy indirect
2,222,222
$4.50
$10.00M
Column Group III Gp, LP
12 Feb 2024
10% owner
Buy indirect
2,222,222
$4.50
$10.00M
Timothy Hoey
29 Aug 2023
Chief Scientific Officer
Sold on a plan
7,243
$4.26
$30.86K
Faraz Ali
16 Aug 2023
Chief Executive Officer
Sell
5,563
$3.81
$21.20K
Leone D Patterson
16 Aug 2023
Chief Fin. and Bus. Officer
Sell
4,452
$3.81
$16.96K
Whittemore Tingley
16 Aug 2023
Chief Medical Officer
Sell
5,563
$3.81
$21.20K
Timothy Hoey
16 Aug 2023
Chief Scientific Officer
Sell
4,007
$3.81
$15.27K
David Goeddel V
10 Mar 2023
Director
Buy indirect
6,779
$2.60
$17.60K
Column Group III Gp, LP
10 Mar 2023
10% owner
Buy indirect
6,779
$2.60
$17.60K
David Goeddel V
8 Feb 2023
Director
Buy indirect
1,500,000
$2.60
$3.90M
Column Group III Gp, LP
8 Feb 2023
10% owner
Buy indirect
1,500,000
$2.60
$3.90M
David Goeddel V
19 Jan 2023
Director
Buy indirect
69,739
$2.50
$174.20K
Column Group III Gp, LP
19 Jan 2023
10% owner
Buy indirect
69,739
$2.50
$174.20K
David Goeddel V
18 Jan 2023
Director
Buy indirect
135,688
$2.52
$341.43K
Column Group III Gp, LP
18 Jan 2023
10% owner
Buy indirect
135,688
$2.52
$341.43K
David Goeddel V
17 Jan 2023
Director
Buy indirect
49,463
$2.49
$123.40K
Column Group III Gp, LP
17 Jan 2023
10% owner
Buy indirect
49,463
$2.49
$123.40K
David Goeddel V
21 Nov 2022
Director
Buy indirect
9,615,384
$2.60
$25.00M
Column Group III Gp, LP
21 Nov 2022
10% owner
Buy indirect
9,615,384
$2.60
$25.00M
Deepak Srivastava
21 Nov 2022
Director
Buy indirect
230,769
$2.60
$600.00K
Eli Casdin
17 Nov 2022
Director
Buy indirect
2,492,042
$2.60
$6.48M
Timothy Hoey
26 Apr 2022
Chief Scientific Officer
Sell
1,353
$10.13
$13.71K
Eli Casdin
3 Aug 2021
Director
Buy indirect
850,000
$15.00
$12.75M
Casdin Partners Master Fund, L.P.
3 Aug 2021
10% owner
Buy indirect
850,000
$15.00
$12.75M

What was left out

Form 4 filings counted 124
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 0
Sales at will 72
Transactions with no price 0
Shares from compensation/vesting 25,322,084
Sales filed before the plan box existed 1
History held since 4 Aug 2021